Sidransky, Ellen
9 papers on CoChatORCID 0000-0002-3019-8500
Most cited papers
- Verified
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 2,135
- Verified
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell
Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research
Cited by 1,341
- Verified
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 475
- Verified
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
Chia, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., et al. (2021) · Nature Genetics
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 438
- Verified
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 433
- Verified
Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Panicker, L. M., Miller, D., Park, T. S., Patel, B., Azevedo, J. L., Awad, O., Masood, M. A., Veenstra, T. D., Goldin, E., Stubblefield, B. K., et al. (2012) · Proceedings of the National Academy of Sciences
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 129
- Verified
Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs
Aflaki, E., Stubblefield, B. K., Maniwang, E., Lopez, G., Moaven, N., Goldin, E., Marugan, J., Patnaik, S., Dutra, A., Southall, N., et al. (2014) · Science Translational Medicine
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 126
- Verified
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes
Daykin, E. C., Ryan, E., & Sidransky, E. (2021) · Molecular Genetics and Metabolism
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 77
- Verified
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., et al. (2022) · Brain
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free